Assignee
XOC PHARMACEUTICALS INC
US·12 granted patents·2 pending applications·52 citations·filing 2016–2020
Top patents by PatentIndex Score
14 records- 0192US9815830B2Isoergoline compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2017·Granted Nov 14, 2017·6 cites·15 claims
- 0292US9777016B2Isoergoline compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2017·Granted Oct 3, 2017·6 cites·12 claims
- 0392US9657020B2Ergoline compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2016·Granted May 23, 2017·10 cites·34 claims
- 0491US9676776B2Isoergoline compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2016·Granted Jun 13, 2017·6 cites·37 claims
- 0590US9951070B2Ergoline compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2017·Granted Apr 24, 2018·6 cites·16 claims
- 0690US9938277B2Ergoline compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2017·Granted Apr 10, 2018·7 cites·18 claims
- 0786US10308651B2Ergoline compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2018·Granted Jun 4, 2019·3 cites·13 claims
- 0886US10246458B2Ergoline compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2018·Granted Apr 2, 2019·3 cites·16 claims
- 0984US10703753B2Ergoline compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2019·Granted Jul 7, 2020·1 cites·12 claims
- 1082US10301311B2Polycyclic compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2018·Granted May 28, 2019·3 cites·16 claims
- 1179US10464936B2Ergoline compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2018·Granted Nov 5, 2019·1 cites·15 claims
- 1271US2021115042A1Ergoline compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1362US10815235B2Polycyclic compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2019·Granted Oct 27, 2020·0 cites·17 claims
- 1442US2016206610A1Methods for treating and/or preventing emesis and/or nausea including acute and/or delayed nausea and/or acute emesis and/or delayed emesisXOC PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →